204 related articles for article (PubMed ID: 37545536)
1. Low T-cell reactivity to TDP-43 peptides in ALS.
Ramachandran S; Grozdanov V; Leins B; Kandler K; Witzel S; Mulaw M; Ludolph AC; Weishaupt JH; Danzer KM
Front Immunol; 2023; 14():1193507. PubMed ID: 37545536
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
4. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
[TBL] [Abstract][Full Text] [Related]
5. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
6. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
[TBL] [Abstract][Full Text] [Related]
7. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis.
Cacabelos D; Ayala V; Granado-Serrano AB; Jové M; Torres P; Boada J; Cabré R; Ramírez-Núñez O; Gonzalo H; Soler-Cantero A; Serrano JC; Bellmunt MJ; Romero MP; Motilva MJ; Nonaka T; Hasegawa M; Ferrer I; Pamplona R; Portero-Otín M
Neurobiol Dis; 2016 Apr; 88():148-60. PubMed ID: 26805387
[TBL] [Abstract][Full Text] [Related]
8. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
9. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
10. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
11. The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes.
Scotter EL; Cao MC; Jansson D; Rustenhoven J; Smyth LCD; Aalderink MC; Siemens A; Fan V; Wu J; Mee EW; Faull RLM; Dragunow M
Mol Cell Neurosci; 2022 Dec; 123():103768. PubMed ID: 36038081
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Expression of Transposable Elements in TDP-43
Valdebenito-Maturana B; Rojas-Tapia MI; Carrasco M; Tapia JC
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555863
[TBL] [Abstract][Full Text] [Related]
13. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
[TBL] [Abstract][Full Text] [Related]
14. The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS).
Kaur K; Chen PC; Ko MW; Mei A; Chovatiya N; Huerta-Yepez S; Ni W; Mackay S; Zhou J; Maharaj D; Malarkannan S; Jewett A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359827
[TBL] [Abstract][Full Text] [Related]
15. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
16. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
[TBL] [Abstract][Full Text] [Related]
17. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
19. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.
Hishizawa M; Yamashita H; Akizuki M; Urushitani M; Takahashi R
Neurochem Int; 2019 Mar; 124():41-45. PubMed ID: 30578840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
